ORGO Organogenesis Holdings Inc. Class A Common Stock PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Organogenesis (ORGO) Stock: Buy, Sell, or Hold?

$0.97
-0.09 (-8.10%) â–ŧ
5d: +14.89% 30d: -15.35% 90d: -46.09%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (83%)
Quality Score
46/100
Position
FAIR
30-Day Fair Range
$0.84 – $1.22
Position: FAIR
Forward P/E & Valuation
-2.0x CHEAP
vs 18.1x historical avg
Wall Street Target
$2.00
+107.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.73 / $1.06
Trend: Strong Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: ORGO is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.

Get Alerted When ORGO Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: ORGO is currently trading at $0.96, which is considered fair relative to its 30-day fair value range of $0.84 to $1.22. From a valuation perspective, the stock is trading at a discount (Forward PE: -2.0) compared to its historical average (18.1). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, ORGO is in a strong downtrend. Immediate support is located at $0.73, while resistance sits at $1.06. Short-term momentum is weak, with the stock down 8.1% recently.

Market Sentiment: ORGO scores 61/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $2.00 (+107.3%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $0.84 - $1.22
Company Quality Score 46/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 83.3%

Trading Range & Key Levels

30-Day Trading Range $0.84 - $1.22
Current vs Trading Range FAIR
Support Level $0.73
Resistance Level $1.06
Current Trend Strong Downtrend
Technical data as of Nov 12, 2026

Quantitative Signal Breakdown

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (61/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-8.1%)
  • BULLISH: Trading 107.3% below Wall St target ($2.00)
  • BULLISH: Market expects only 0% annual growth - appears undervalued
  • WARNING: Composite score 46/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -1.97
Wall Street Target $2.00 (+107.3%)
Revenue Growth (YoY) -69.9%
Earnings Growth (YoY) 555.2%
Profit Margin -38.5%
PE vs Historical -2.0 vs 18.1 CHEAP
Share ORGO Analysis

Share this live ORGO analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (ORGO)

Bullish 1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jul 17, 2026
Daily AI digest
AI Retail Discussion Summary: StockTwits shows 100.0% bullish sentiment towards $ORGO with no recent news articles available.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 6:24 PM ET
Data refreshes hourly during market hours. Next update: 7:24 PM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for ORGO.

Create Free Account

Already have an account? Log In

Top Rated Drug Manufacturers - Specialty & Generic Stocks

Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NBIX
Neurocrine Biosciences Iâ€Ļ
STRONG BUY
29 analysts
$208 23 SELL
ALKS
Alkermes Plc
STRONG BUY
20 analysts
$58 41 HOLD
AQST
Aquestive Therapeutics Iâ€Ļ
STRONG BUY
9 analysts
$9 60 BUY
TEVA
Teva Pharma Industries Lâ€Ļ
STRONG BUY
15 analysts
$49 36 SELL
HROW
Harrow Health Inc
STRONG BUY
9 analysts
$63 51 HOLD

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive ORGO Research Pages
ORGO Technical Chart ORGO Price Prediction ORGO Intrinsic Value DCF ORGO Earnings Date Why is ORGO Moving Today? ORGO Investment Advisor ORGO Fair Price Analyzer ORGO Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals